Brief: Sio Gene Therapies Announces Receipt Of $11.6 Million From Closing Of The Sale Of Arvelle Therapeutics
04/02/2021 12:51
Feb 4 (Reuters) - Sio Gene Therapies Inc SIOX.O :
* SIO GENE THERAPIES ANNOUNCES RECEIPT OF $11.6 MILLION FROM
CLOSING OF THE SALE OF ARVELLE THERAPEUTICS
Source text for Eikon: ID:nGNX9zfLk3
Further company coverage: SIOX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sio Gene Therapies
See all newsBrief: Sio Gene Therapies Inc - On March 14, Got Notice That Nasdaq Has Determined That Company's Common Stock Will Be Delisted From Nasdaq Capital Market
Brief: Sio Gene Therapies Announces Fiscal Third Quarter 2022 Financial Results
Brief: Sio Gene Therapies Inc. Announces Board Approval Of Plan Of Complete Liquidation, Dissolution
Brief: Sio Gene Therapies Announces Second Quarter Financial Results
Brief: Sio Gene Therapies Announces Fiscal First Quarter 2022 Financial Results